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Background: Post-discharge support is a key component of effective treatment for hospitalized smokers, but few
hospitals provide it. Many hospitals and care settings fax-refer smokers to quitlines for follow-up; however, less than
half of fax-referred smokers are successfully contacted and enrolled in quitline services. “Warm handoff” is a novel
approach to care transitions in which health care providers directly link patients with substance abuse problems
with specialists, using face-to-face or phone transfer. Warm handoff achieves very high rates of treatment
enrollment for these vulnerable groups.
Methods: The aim of this study—“EQUIP” (Enhancing Quitline Utilization among In-Patients)—is to determine the
effectiveness, and cost-effectiveness, of warm handoff versus fax referral for linking hospitalized smokers with
tobacco quitlines. This study employs a two-arm, individually randomized design. It is set in two large Kansas
hospitals that have dedicated tobacco treatment interventionists on staff. At each site, smokers who wish to remain
abstinent after discharge will be randomly assigned to groups. For patients in the fax group, staff will provide
standard in-hospital intervention and will fax-refer patients to the state tobacco quitline for counseling post-
discharge. For patients in the warm handoff group, staff will provide brief in-hospital intervention and immediate
warm handoff: staff will call the state quitline, notify them that a warm handoff inpatient from Kansas is on the line,
then transfer the call to the patients’ mobile or bedside hospital phone for quitline enrollment and an initial
counseling session. Following the quitline session, hospital staff provides a brief check-back visit. Outcome
measures will be assessed at 1, 6, and 12 months post enrollment. Costs are measured to support cost-effectiveness
analyses. We hypothesize that warm handoff, compared to fax referral, will improve care transitions for tobacco
treatment, enroll more participants in quitline services, and lead to higher quit rates. We also hypothesize that
warm handoff will be more cost-effective from a societal perspective.
Discussion: If successful, this project offers a low-cost solution for more efficiently linking millions of hospitalized
smokers with effective outpatient treatment—smokers that might otherwise be lost in the transition to outpatient care.
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Post-discharge support is a key component of effective
treatment for hospitalized smokers, but very few hospi-
tals provide it [1]. Linking hospitalized smokers with
tobacco quitlines is an ideal way to provide supportive
contact at discharge. Proactive tobacco quitlines are ef-
fective and cost-effective for smoking cessation [2,3];
they are freely available to many US smokers [4]; ser-
vices are delivered via telephone, which minimizes many
access barriers; hospitals do not have to bear the costs of
the services; and many quitlines are undersubscribed
and eager to increase their reach [5,6].
In the last 10 years, several health care facilities have
adopted the practice of providing fax referrals to state
quitlines in an effort to link smokers with ongoing sup-
port [7-9]. This practice has produced mixed results.
Studies conducted within primary care settings docu-
ment conversion rates from fax referral to enrollment
varying from 16-42% [10,11]. Unfortunately, no such
studies have been conducted primarily among hospital
patients, so the conversion rate from fax referral to en-
rollment among hospitalized patients is not known. Our
own 6-month follow-up data among University of Kan-
sas Hospital (KUMed) patients found that only 5% of
patients fax-referred to the quitline reported they had
participated in quitline services [12]. Moreover, no stud-
ies have yet reported the effectiveness of fax referral on
long-term quit rates. Hence, fax referral is a promising
but unproven method for linking smokers with post-
medical care support.
Integrated Behavioral Health (IBH) and Screening,
Brief Intervention, and Referral to Treatment (SBIRT)
programs offer another model of linking hospital
patients with quitlines post-discharge. IBH is a national
initiative to integrate behavioral health services into pri-
mary care settings [13,14], and SBIRT is a federal dem-
onstration program to institute a system of universal
screening, brief intervention, and referral to treatment
for persons with substance abuse in medical care set-
tings [15]. Program evaluation data on 459,599 patients
from six states suggest that SBIRT is feasible to imple-
ment and results in self-reported improvement in drug
and heavy alcohol use, as well as health status, among
recipients of services [16]. Some SBIRT services have
adopted the practice of “warm handoff.” In this model,
health care providers walk the patient to a behavioral
health care provider who is co-located in the medical
setting. The behavioral health provider enrolls and initi-
ates treatment before the patient leaves the acute-care
setting. At present, few published reports of the effect-
iveness of warm handoff are available. One report found
80% of patients attended their first appointment with
their health care provider after being transferred via
warm handoff, as opposed to 20% who were referred byword or paper recommendation; another reported warm
handoff achieved 80%-90% enrollment, as opposed to
10% enrollment via less intensive referral methods [17,18].
An evaluation of warm handoff as a method of tran-
sitioning patients to post-discharge care would be valu-
able for hospitals that wish to comply with proposed
new US Joint Commission Accreditation of Healthcare
Organization (Joint Commission) guidelines. These
guidelines recommend universal screening for tobacco,
brief intervention for all who screen positive, referral
for post-discharge treatment, and post-discharge follow-
up to assess outcomes and ensure the patient has en-
rolled in treatment. These measures will encourage
hospitals to ensure smokers receive evidence-based
treatment after discharge.
This project, Enhancing Quitline Utilization among
In-Patients (EQUIP), is funded by the National Heart,
Lung, and Blood Institute (U01 HL105232-01) and is
part of an NIH Cooperative Agreement. The research
teams funded under this cooperative agreement have be-
come a consortium and adopted the name of “CHART”
(Consortium of Hospitals Advancing Research on
Tobacco). The overall goal of the project described in
this article is to determine the relative effectiveness, and
cost-effectiveness, of warm handoff versus fax referral in
linking hospitalized smokers with quitline services. We
hypothesize that, compared to patients receiving fax re-
ferral, more patients in the warm handoff condition will
enroll in quitline services, have an initial counseling ses-
sion, and participate in follow-up sessions post dis-
charge. We believe the active ingredient in the
intervention is the chance to sample quitline participa-
tion prior to hospital discharge and that this experience
will lead more smokers to accept follow-up calls after
going home. Ultimately, enrolling in quitline services
and adhering to counseling should lead to higher rates
of cessation. The intervention was designed to be simple,
translatable, and sustainable to enhance its potential for
widespread adoption and ultimate impact on public
health. This paper describes the study protocol.
Methods/Design
Overview of design and setting (Figure 1)
We employ a control-group design with individual
randomization to study arms—warm handoff versus
fax referral. The study will be conducted over a 4-year
period. Participants will be hospitalized smokers from
two large hospitals that have dedicated tobacco treat-
ment services. Dedicated hospital treatment staff will
screen smokers referred to services for eligibility, and
collect informed consent and baseline data. Afterwards,
they will randomize patients to study arms, conduct
in-hospital intervention, and refer enrolled smokers to
quitline according to their study arm. Research staff
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Figure 1 Overview and study design of EQUIP – a randomized
controlled trial.
Richter et al. Trials 2012, 13:127 Page 3 of 11
http://www.trialsjournal.com/content/13/1/127will collect 1-, 6-, and 12-month follow-up data.
Outcome measures and analyses include 30-day point
prevalence abstinence at 6 months, biochemically veri-
fied 7-day point prevalence, quitline enrollment and ad-
herence, and cost effectiveness. The tobacco quitline
vendor for Kansas will provide process data on counsel-
ing enrollment and adherence. We estimate 994 partici-
pants will be required to detect the treatment effect.
We will recruit the majority of patients (700) from the
University of Kansas Hospital (KUMed) in Kansas City,
and the remaining 294 from Stormont Vail Regional
Health Center in Topeka, Kansas. KUMed is a 600-bed
academic medical center; its tobacco treatment service
(UKanQuit) was founded in 2006. Stormont Vail is a
586-bed acute care referral center for Northeast Kansas;
its tobacco treatment service is new and was developed
for the purpose of implementing this trial. The training
and experience of UKanQuit staff range from Associ-
ates Degrees with lengthy experience in substance
abuse treatment to Masters’ Degrees in counseling. Staff
has received tobacco treatment specialist trainings at
accredited programs.
Identifying hospitalized smokers
Approximately 800 patients are referred to UKanQuit at
KUMed each year. Patients are referred via provider
orders and self-referral. Numerous providers can enterorders for tobacco treatment at any time during a
patients’ hospital stay. Self-referral is via automated
prompts delivered to patients by the electronic medical
record (EMR) during admission. As nurses record infor-
mation from patients admitted to their units, the EMR
requires them to identify the smoking status of all
patients and to ask all smokers if they would like to talk
to a tobacco treatment specialist during their hospital
stay. The patients who respond “yes” and also those
whose physicians request treatment orders are placed on
an electronic list for the tobacco treatment service. In
addition to referrals, the UKanQuit service staff can view
and actively recruit from a list of all smokers in the hos-
pital at any given time. Stormont Vail has no tobacco
treatment order or request system. Their smokers will
be identified via a tobacco user list generated from the
EMR.
Recruitment, baseline assessment, consent, and
randomization (Figure 2)
At both study sites, UKanQuit staff will receive training
regarding screening participants, collecting consent, and
conducting the warm handoff intervention. UKanQuit
staff already provides fax referral to quitline as a part of
their usual duties. During the study recruitment period,
UKanQuit staff will, as usual, visit all referred hospita-
lized smokers at bedside. Patients may enroll in the
study only once. Study staff will first check the patients’
medical record against a list of medical records for all
current study participants to prevent enrolling the same
patient multiple times. Staff will briefly describe the
study and screen for eligibility/interest in participating
in the study. They will provide treatment as usual, in-
cluding fax referral to quitline, to patients who are not
eligible or willing to participate. Among patients who
are willing to participate, staff will collect informed con-
sent via a simplified, one-page consent form developed
for the trial. UKanQuit staff will then conduct a brief
baseline assessment, conduct random assignment, and
provide intervention/referral according to the study arm
to which the patient was assigned. In order to ensure
that equal numbers of patients are assigned to interven-
tion and control conditions, we will conduct block
randomization between the two sites and across the
three sources of referral (proactive recruitment among
all smokers, physician orders, and patient requests to see
specialists).
Participants
Hospital patients who smoke and have been referred for
tobacco treatment will be eligible for enrollment. Eligi-
bility criteria are listed in Table 1. We exclude non-
Kansans because residents of other states may receive
quitline services from a different vendor, which would
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Figure 2 Recruitment of participants into EQUIP.
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obtain quitline adherence data. Participants who are
ineligible or who refuse to participate during one
hospitalization will be screened and enrolled at a laterTable 1 Eligibility criteria
• Current smoker (within the past 30 days)
• Aged 18 years or older
• Lives in Kansas
• Wishes to remain abstinent from tobacco post-discharge
• Plans to remain a resident of Kansas post-discharge
• Speaks English or Spanish
• No significant co-morbidity or issue that would prevent participation
(e.g., acute life-threatening medical illness, communication barriers,
altered mental status, etc.) as determined by hospital or research staff
• Has access to a telephone post-discharge
• Does not have another household member participating in this study
• Is not currently pregnantdate if they meet study criteria and agree to participate
during subsequent hospitalizations.
Intervention and control arm procedures (Table 2)
Patients in both study arms will receive the hospitals’
standard cessation brochure with information and
resources on quitting smoking. For patients in the fax-
referral group, UKanQuit staff will provide the standard
in-hospital intervention and will fax-refer patients to the
state tobacco quitline for counseling post-discharge. For
patients in the warm handoff group, the UKanQuit staff
will provide an abbreviated in-hospital intervention,
warm handoff to the quitline, and a brief check-back
visit.
Fax referral group
UKanQuit, and the tobacco treatment service as Stor-
mont Vail, deliver in-hospital treatment that was adapted
from the inpatient intervention provided at Massachu-
setts General Hospital. UKanQuit screening and inter-
vention procedures are described more fully elsewhere
Table 2 In-patient treatment, warm handoff versus fax
Warm Hand-Off Fax
Staff brief intervention and warm handoff (5 min): Staff standard in-patient session: (20 min):
• Assess withdrawal, need for medication change • Assess withdrawal, need for medication change
• Describe warm handoff process • Conduct assessment of smoking history, interest in quitting
• Provide cessation brochure • Explore thoughts/feelings toward quitting
• Perform call, leave room • Provide cessation brochure
• Notify patients’ nurse that patient is talking to quitline • Provide medication education
Quitline session (20 min): • Build plan to stay quit
• Collect minimum data set • Describe fax referral process
• Explore thoughts/feelings toward quitting • Ask if patient requests cessation medication script on discharge
• Provide medication education
• Build plan to stay quit
• Schedule next call
Staff check-back (5 min):
• Ask patient how session went
• Ask if patient requests cessation medication script on discharge
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working with nurses and physicians to adjust nicotine
replacement to keep the patient comfortable while in the
hospital; (3) assessing patients’ interest in quitting smok-
ing (e.g., remaining abstinent after discharge); (4) provid-
ing a brief motivational intervention to patients not
interested in quitting; (5) providing assistance in quitting
(arranging for medication scripts on discharge, arranging
for follow-up with quitline; developing a quit plan); and
(6) documenting treatment in the electronic medical rec-
ord. UKanQuit intervention procedures are highly stan-
dardized and include data collection forms, a quit plan,
and intervention checklists to facilitate supervision of
counseling procedures by the clinic director and coord-
inator. Staff fax-refer patients to the quitline on the day
they are discharged from the hospital, to ensure patients
receive a call from the quitline soon after arriving at
their home or residential facility.
Warm handoff group
Brief intervention, warm handoff, quitline enrollment/
counseling, and check-back are designed to last a total
of 30 min. During their initial brief intervention, UKan-
Quit staff will assess withdrawal, describe warm transfer
procedures, perform the handoff, and leave the room.
UKanQuit staff will perform the handoff by calling the
quitline, notifying the quitline that an inpatient from
Kansas is on the line, then transferring the call to the
patients’ mobile or bedside hospital phone for quitline
enrollment and, time permitting, an initial counseling
session with an Alere Quit Coach. During the quitline
call, the hospital counselor will notify the patient’s nursethat the patient is participating in quitline telephone
counseling. The counselor may use this time to work
with the patient’s health care team to adjust inpatient
nicotine replacement, if the patient reported withdrawal
and craving. After the quitline session, the counselor will
check back with the patient and provide further assist-
ance, such as arranging for medication scripts on dis-
charge in consultation with the patients’ health care
team. The counselor will document the intervention in
the medical record.
Troubleshooting handoffs and referrals
As with standard inpatient counseling, UKanQuit staff
may initially find patients occupied with hospital proce-
dures, but will return when patients are free to partici-
pate in counseling. Similarly, at times counseling
sessions are interrupted by hospital procedures. If the
procedure will be brief, the counselors will wait and re-
sume the session afterwards. However, if the procedure
will be lengthy, the counselor will return at a later time.
Should patients be interrupted during a quitline call, the
Quit Coach and patient may opt to complete enroll-
ment, which requires approximately 5 min, and schedule
the initial counseling session for a later time in the day
or for a day post-discharge. Hospital staff carry smart
phones to receive pages from hospital units, check
emails, and call physicians to discuss patient medica-
tions; this will enable them to check with nurses on
patients’ availability and perform warm handoffs while
present in patients’ rooms.
Arranging for medications at discharge is a very im-
portant function of hospital treatment. We instituted the
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the opportunity to request changes in inpatient cessation
medication as well as medication on discharge, based on
their discussions with their quitline coaches.
In the fax group, the patient gets counseling that is
similar to quitline counseling, but is provided by the
hospital tobacco treatment (UKanQuit) staff. At the
close of the session, UKanQuit staff asks the patients if
they would like to change their inpatient medication or
request a prescription for medication on discharge.
Hence, the fax referral group doesn’t need a check
back because the counselor never leaves the room. The
check back for warm hand off patients provides an
interface between the quitline coach and the hospital
staff, and gives equal opportunity for patients in the
warm hand off group to obtain cessation medications.
If warm hand off to quitlines should become dissemi-
nated widely, the check back would be a key role for
nursing staff or other care providers, because without
it patients could leave the hospital without being
offered prescriptions for cessation medications, which
would fail to fulfill new Joint Commission guidelines
for tobacco treatment.
Quitline services
The Kansas Department of Health and Environment
(KDHE) contracts with Alere Wellbeing (Formerly Free
& Clear) for quitline services. Participants who accept
referral to the quitline and enroll in quitline services will
receive three to eight proactive counseling calls, depend-
ing on their intake assessment and interest in continued
counseling. Each call is designed to provide practical ex-
pert support to help participants develop problem-solving
and coping skills, secure social support, and design a plan
for successful cessation and long-term abstinence.
Hospital tobacco treatment staff fidelity monitoring
We will assess UKanQuit staff fidelity to treatment to
ensure both study arm interventions are well implemen-
ted and the trial is a valid test of warm handoff versus
fax referral. Components of the intervention that require
fidelity control include (1) completing all steps of the in-
hospital intensive intervention, (2) accurately describing
the referral procedure to the patient, (3) making the re-
ferral, (4) completing the referral in the correct time
frame, and (5) correctly filling out referral forms. Fidelity
to components 1–3 will be assessed in person during
hospital consults. Fidelity to usual care will be measured
using a checklist that outlines intervention components
for usual care. Any deviations from usual care, including
enhanced care not included in the protocol, will be
noted, and hospital staff will receive corrective feedback
on this. Research staff will accompany each hospital staff
member on a 5% sample of randomly selected hospitalsessions and use checklists to assess fidelity to in-
hospital study components. Fidelity to components 1
and 4–5 will be assessed for the same sample of visits by
records inspection. Research staff will check EMR en-
tries for patients to assess completeness of documenta-
tion. Staff will interface with our quitline collaborators
to collect dates of referral and copies of referral forms
(for fax referrals only) to assess whether referrals were
made, and made correctly. Data on fidelity to procedures
for each study arm will be entered into a database and
reported back to hospital staff on a monthly basis to en-
courage adherence to protocols.
Data collection
Baseline assessment will be conducted prior to
randomization by UKanQuit staff. Follow-up assess-
ments will be conducted by research assistants; assess-
ments occur at the following post-randomization times
and reimbursement levels: 1 month ($20); 6 months
($50), and 12 months (EMR data download for health
care utilization only—no reimbursement provided). In
addition, participants who provide salivary cotinine sam-
ples following the 6-month assessment are reimbursed
$100. Research assistants will be fluent in English and
Spanish. We will reimburse participants for all assess-
ments. The project has collaborated with other CHART
members on the development and use of standardized
measures, methods, and data management.
Study measures (see Table 3)
We will collect all CHART core measures (see Riley
et al., lead paper in this special issue). Our baseline
measure is designed to be brief to preserve time for
intervention, and minimize the burden on patients and
the potential for UKanQuit staff to be interrupted by
other hospital staff who must attend to patients. To as-
sess mediation, at 1 month post-randomization we will
collect items adapted from the Care Transition Measure
(CTM-15) [20], adapted for tobacco treatment, to assess
patients’ perceptions of how well the two conditions
(warm handoff versus fax) facilitated the transition to
outpatient tobacco care. Quitline enrollment is defined
as having completed the quitline’s enrollment assess-
ment. Adherence to counseling will be measured via a
count variable that can range from 0–5, which corre-
sponds to the number of sessions completed. In
addition, we will form a composite measure of comple-
tion of guideline-recommended levels of counseling.
This will be a binary measure of whether participants
completed at least 1 month of counseling follow-up (at
least three counseling sessions post-discharge). The data
for these measures will be derived from Alere reports.
We collect data for several main outcomes measures.
The CHART main outcome measure is 30-day self-
Table 3 Study measures by assessment time point*
Time points: Baseline Mo. 1 Mo. 6 Mo. 12
Self-reported smoking
abstinence
30-day point prevalence ✓ ✓ ✓
7-day point prevalence ✓ ✓ ✓
Salivary cotinine ✓
Prolonged abstinence ✓ ✓ ✓
Time to relapse ✓ ✓ ✓
Quit date ✓
Smoking and quitting history
Cigarette use in past 30 days ✓
No. days smoked in past 30 days ✓
Age started using tobacco ✓
No. of quit attempts ✓ ✓ ✓
No. of cigarettes smoked per day ✓ ✓ ✓ ✓
Medications used to quit ✓ ✓ ✓
Resources used to quit ✓ ✓ ✓
Other forms of tobacco,
no. of days used
✓ ✓ ✓ ✓
E-cigarette use ✓ ✓ ✓
Smoking during hospitalization ✓
Other tobacco during
hospitalization
✓
Time to first cigarette ✓
Around tobacco users at
home/work
✓
Home smoking restrictions ✓
Other household smokers ✓
Stages of change ✓
Readiness to quit ✓
Quitline use
Enrolled in quitline ✓
No. quitline calls completed ✓
Length of quitline calls ✓
Co-morbidities
Body mass index ✓
Co-morbidities ✓
Hospitalization factors
Health insurance ✓
Prescription drug coverage ✓
Length of stay
(admit/discharge time/date)
✓
Discharge diagnoses
(primary/secondary)
✓
Procedure codes,
diagnosis-related group (DRG)
✓
Discharge plan ✓
Table 3 Study measures by assessment time point*
(Continued)
Admit via emergency,
admitting hospital service
✓
Transitions in tobacco care ✓
Hospitalization/access to care** ✓ ✓ ✓ ✓
Depression and alcohol use
Patient Health Questionnaire (PHQ)-2 ✓ ✓ ✓ ✓
AUDIT-C*** ✓
Demographics
Race, ethnicity, age, sex, education ✓
Marital status, income, employment ✓
*Excluding cost-effectiveness measures.
**From the National Health And Nutrition Examination Survey (N-HANES).
*** Alcohol Use Disorders Identification Test, version C.
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has defined its own secondary outcome measure for
7-day, biochemically/proxy-verified smoking cessation
at 6 months.
Five CHART sites are also conducting a sub-study of
cotinine verified abstinence and are collecting biochem-
ical verification using the same protocols in order to fa-
cilitate pooled analysis of verification data. The data
collection process, cotinine analytic methods, and cut-
offs are described in detail by Riley et al. in a separate
article in this issue. Briefly, all patients who self-report
being abstinent from tobacco for the 7 days preceding
their 6-month survey, and who are not on nicotine re-
placement therapy, will be invited to provide a mailed
salivary cotinine sample. They will be reimbursed $100
for the sample. Study staff follows an aggressive 30-day
follow-up protocol involving multiple phone reminders,
sample kit mailings, and an offer to meet the partici-
pant to collect the sample in their homes. Any partici-
pants who fail to provide samples within 30 days of
their self-report are considered to be smokers.
In addition to biochemical verification via mailed saliv-
ary cotinine, EQUIP participants may also be considered
abstinent under two conditions. First, participants who
report they are abstinent may fail or refuse to provide a
saliva sample but nominate a proxy to verify their smok-
ing status. Staff will contact the proxy; if the proxy veri-
fies tobacco abstinence, the smoker will be considered
abstinent. Second, study participants who report tobacco
abstinence but who are taking nicotine replacement
therapy may provide an in-person expired-air carbon
monoxide (CO) sample. If they provide a CO of
<10 ppm, they will be considered abstinent.
We will assess cessation pharmacotherapy lifetime use
and use in the past 30 days at baseline. To assess medi-
cation use any time during the study and in the past
30 days, we will follow the method of Williams et al.
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each medication was used.
Study hypotheses (Table 4)
We hypothesize that warm handoff will achieve higher
quit rates because it will facilitate transitions in care.
Warm handoff will increase the proportion of referred
smokers who enroll in quitline services, compared to fax
referral. Across both study arms, smokers who enroll in
quitline services will receive level 4 intensity treatment
(intensive inpatient treatment plus more than 1 month
follow-up), and smokers who do not enroll will receive
level 2 intensity treatment (intensive inpatient treatment
but no follow-up, as defined in the recent Cochrane
Review of Interventions for Smoking Cessation in Hospi-
talized Patients) [1]. Hence, quitline enrollment, adher-
ence, and other evidence-based aspects of active
tobacco treatment such as cessation medication use
will be important mediators for study outcomes.
Costs for cost-effectiveness analyses
To assess intervention costs, for those randomized to
the fax group, costs associated with completing and
transmitting the fax form to the quitline will be assigned
a standard time charge. For the warm handoff arm,Table 4 Study hypotheses, measures, and analytic strategies
Purpose Variables
First aim: Main study outcomes Treatment
Hypothesis 1 • Enrollmen
Test the effects of warm handoff on quitline enrollment
Hypothesis 2 Treatment
Test the effects of warm handoff on post-discharge
guideline-based counseling adherence
• Completi
sessions (b
Hypothesis 3 Treatment
Test the effects of warm handoff on 6-month
abstinence outcomes
• 30-day ab
• 7-day abs
• Prolonge
Second Aim: Mediation analyses Treatment
Hypothesis 4 • Satisfactio
Effect of warm handoff on care transitions, enrollment,
adherence, and pharmacotherapy utilization
• Enrollmen
• No. of qu
• Pharmaco
Third aim: Costs and cost-effectiveness Treatment
Hypothesis 5 • 30-day ab
Warm handoff will be more costly, but also
more cost-effective, than fax referrals
• Fixed/Var
• Provider
• Participan
Feasibility, strengths/weaknesses of protocols Semistructcounselors will track their time assisting with the three-
way call to the quitline prospectively at the participant
level. A standard per minute charge will be assigned to
fax and telephone costs. Counselors at the quitline also
will track their time prospectively as they interact with
study participants by treatment arm. Personnel time will
be valued at local wages plus benefits. In addition to
program-borne costs, we will also add participants’ time
costs consistent with their counselor time with costs
valued at participants’ estimated hourly wages.
To assess short-term health care costs at 6 and
12 months, we will ask participants about their use of
inpatient and outpatient health care resources, including
what type of services (hospital stays, emergency depart-
ment visits, general medicine and specialist physician
visits) they used and how often. Although patients’ self-
report of health care visits may either over or under re-
port contact with providers, self-report is the least costly
method of collecting data about health care use [23,24].
Since patients’ out-of-pocket expenses for these services
will not accurately reflect the service value, we will use
Medicare national fee structures to value the costs of
these services.
We will estimate the costs of pharmacotherapy at the
person level based upon retail prices documentedAnalytic strategy
condition and: Logistic regression
t in quitline by 6 months
condition and: Logistic regression
ng at least 3 quitline counseling
inary)
condition and: Logistic regression
stinence
tinence
d abstinence
condition and 1-month: Combined Poisson and logistic
structural equation modeling
n with care transition
t in quitline
itline sessions completed
therapy use
condition and: -Average cost/arm
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websites, e.g., www.drugstore.com and www.walgreens.
com. Finally, we will track participants’ lost work days in
the first 6 months to assess indirect costs.
Hospital tobacco treatment staff satisfaction and
recommendations for improvement
To assess the feasibility of the intervention for dissemin-
ation, we will use face-to-face semi-structured interviews
to assess UKanQuit staff ’s satisfaction with the study in-
cluding fax and warm handoff referral of inpatients.
Questions will cover overall satisfaction, strengths, weak-
nesses, and recommendations for improvement.
Treatment crossover
There is some potential for treatment crossover, in
which patients in the fax referral arm begin to call the
quitline from their hospital beds once they hear that
patients in the warmhand off condition are contacting
the quitline before discharge. In our experience, patients
do not seem to communicate much with other
patients—even patients sharing the same room. Because
hospital stays are so short, only one in four patients
smoke, and only half of our hospital beds are in two-
patient rooms, it is not common to find two smokers in
the same room for any length of time.
We are not sure how to reduce the likelihood that
crossover occurs, but we will be able to monitor it. We
will monitor the number of fax patients who contact the
quitline prior to discharge by comparing patients’ date
of discharge, which we will obtain from the electronic
medical record, to the date of their enrollment in the
quitline, which we will obtain from the quitline. Regard-
less of whether crossover occurs, all patients will be ana-
lyzed in the groups to which they were assigned, using
an intent-to-treat analysis. However, if crossover occurs
we will be able to describe the prevalence of these events
and perform sensitivity analyses on the data by removing
patients that crossed over and examining outcomes
among the subset of patients that received the treatment
to which they were assigned.
Sample size justification and analyses
Our main outcome measure is 30-day point prevalence
abstinence smoking cessation at 6 months post enroll-
ment. We estimate our quit rate to be 9% in the control
group and 15% in the treatment group, based on prior
research [25,26]. We used formulas from Fleiss et al.
(2003) [27] to calculate sample size. Assuming (1) a two-
tailed alpha = 0.05 and power = 0.80; (2) intent-to-treat
smoking cessation rates of 9% and 15% for fax referral
and warm handoff, respectively; (3) a dichotomous out-
come of biochemically verified 7-day abstinence at
12 months; a minimum of 994 participants are necessaryto test primary effects. We also conducted power ana-
lyses for the proposed mediation models [28]. Analyses
found sample sizes well short of 994 are sufficient for
detecting mediation.
Table 4 outlines our study hypotheses and analyses.
Data analyses include preliminary analyses to assess
data quality and evaluate whether randomization
achieved demographically equivalent study groups, out-
come analyses, mediation analyses, qualitative analyses
of staff and patient interviews, and cost analyses. Prior
to initiating outcome analyses, we will examine fre-
quency distributions for all variables, with particular at-
tention to variable ranges, missing values, skewness and
kurtosis (for continuous variables), and extreme unba-
lancedness in outcome proportions. Participants with
missing outcome data will be retained in analyses but
coded as smokers.
Our primary hypothesis (Hypothesis 3, Table 4) is that
a significantly higher proportion of smokers receiving
warm handoff will become enrolled in quitline services
compared to smokers receiving fax referral. The primary
analysis for Hypothesis 1 will be a comparison of 30-day
point-prevalence abstinence at 6-month enrollment rates
using logistic regression. The regression model will in-
clude a main effect term for group. An adjusted odds
ratio for enrollment (and its confidence interval) will be
computed. Covariates will be added as indicated by uni-
variate analyses of baseline data. A number of other
study hypotheses focus on other tobacco use outcomes,
treatment utilization, and mediators of outcome. For
analyses using structural equation modeling, missing
data will be addressed either by employing full-
information estimation algorithms or by first imputing
missing data and treating input data as complete.
Our third aim is to examine the cost-effectiveness of
warm handoff relative to fax referral. We anticipate that
the warm handoff referral will be more costly and more
effective than fax referral. The primary cost-effectiveness
analysis will be set up as an incremental cost-
effectiveness ratio (ICER). Incremental cost-effectiveness
analysis identifies the marginal benefit of switching from
one intervention to the other and is the ratio of the dif-
ference in costs divided by the difference in effectiveness
between the two treatment options. The ICER will indi-
cate the added cost per additional quitter for warm
handoff versus fax referral, a metric that will allow com-
parisons to other smoking cessation economic studies.
Given that all costs are short term (6–12 months), we
will not discount either costs or benefits. Costs will be
tracked from a societal perspective. The societal per-
spective sums all costs to all parties, including costs to
the health care providers, to patients, and to third party
payers. It is an estimate of the total cost to “society” for
a treatment or intervention, as opposed to the costs for
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patient, or cost to the provider (physician offices).
We will also examine hospital staff satisfaction with
intervention. Satisfaction survey items will be summar-
ized using means and frequencies. Semistructured inter-
views will be analyzed using a qualitative software
package. Transcribed interviews will be open-coded,
identifying within the text key words, themes, and
descriptions of behavior [29]. Subsequently, themes will
be grouped into coding categories, and a code map will
be developed that will allow us to categorize and retrieve
core themes. Findings will also be used to strengthen fu-
ture replications/adaptations of procedures.
Data management
Research assistants will collect data on outcomes and
costs, and will be responsible for entering data. The pro-
ject director will conduct quality control on data collec-
tion and entry. The data manager will conduct initial
data cleaning, identifying and tagging any crossovers,
conversion into proper format for data analysis, and re-
coding using standard operating procedures.
Discussion
This project is innovative as it potentially shifts current
clinical practice by identifying sustainable methods for
extending hospital care beyond discharge. The interven-
tion we employ is novel as it capitalizes on the rise of qui-
tlines as a universally accessible form of counseling care.
It is highly responsive to recent changes in hospital care,
in which primary care providers no longer attend their
patients in the hospital but rely on inpatient “hospitalists”
to provide care [30]. This has created a break in continuity
of care that requires better communication and system
linkages between in- and outpatient providers.
The project is significant because it addresses quality of
hospital care for the most deadly preventable illness in the
US; it addresses the under-researched area of post-
discharge care; it describes rates of treatment uptake and
adherence for a widely used but unevaluated practice (fax
referral); it will evaluate the effectiveness and cost effective-
ness of a novel approach for transferring care (warm hand-
off); and the findings of the trial will provide insight into
how to more effectively address a systemic problem in the
US health care system, namely, transitions in care. If effect-
ive, the intervention could be adapted for use in other
types of interventions, for example, hospital staff could fa-
cilitate enrollment in text messages or web-based pro-
grams to inpatients’ mobile telephones prior to discharge
to help patients prepare for cessation post-discharge.
The study has several limitations. It assesses the effects
of a single course of treatment for tobacco dependence,
however, many smokers may require multiple aided quit
attempts to successfully quit. Our fidelity monitoring forintervention procedures involves having a supervisor ob-
serve treatment encounters, however, counselors will
know they are being observed. Hence, the monitoring
may fail to identify all inconsistencies in counseling pro-
cedures. Last, the intervention requires access to a free,
proactive quitline that provides multiple treatment ses-
sions for all smokers, regardless of insurance or income
status. It will be poorly generalizable, however, if states
continue to cut funding for and access to quitlines.
Hospitals and quitlines represent two excellent treat-
ment systems that could, working together, potentially
provide high-quality and low-cost treatment solutions
for smokers. Identifying the best way to provide a
seamless transition to outpatient care will make this
potential a reality for the millions of smokers who enter
US hospitals annually. Effect size differences between
fax and warm handoff, although small, would have a
significant public health impact because the prevalence
of smoking in hospitals is high and the health effects of
tobacco are so devastating. Multiplied across the mil-
lions of smokers admitted to hospitals each year, these
improved outcomes could result in highly significant
reductions in tobacco use and tobacco-related morbid-
ity and mortality.
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